Given the distinct functional roles of the inositol polyphosphate phosphatases on AKT isoform signalling and the potential oncogenic effects of phosphatases such as INPP4B, examination of the lipid phosphatase signalling networks dysregulated in specific cancers may identify novel drug targets or therapeutic approaches. This evidence concerns the gene AKT1 and cancer.